Last updated on October 2017

Harvoni in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea


Brief description of study

The primary objective of this post-marketing surveillance study is to collect and assess data related to the safety and effectiveness of Harvoni® (ledipasvir/sofosbuvir (LDV/SOF)) treatment regimen, per the approved Korea prescribing information for Harvoni, in routine clinical practice in Korea and to report the results to the Ministry of Food and Drug Safety (MFDS). Patients will be treated as part of routine practice at Korean healthcare centers by accredited physicians.

Clinical Study Identifier: NCT02951364

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Gilead Study Team

Konkuk University Chungju Hospital
Chungju, Korea, Republic of
  Connect »

Gilead Study Team

Soonchunhyang University Cheonan Hospital
Cheonan, Korea, Republic of
  Connect »

Gilead Study Team

Hallym University ChunCheon Sacred Heart Hospital
Chuncheon, Korea, Republic of
  Connect »

Gilead Study Team

GangNeung Asan Hospital
Gangneung-si, Korea, Republic of
  Connect »